BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7471057)

  • 21. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall.
    Scaringi L; Cornacchione P; Rosati E; Fettucciari K; Rossi R; Marconi P
    Cell Immunol; 1994 May; 155(2):265-82. PubMed ID: 8181065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic control of the decline of natural killer cell activity in aging mice.
    Mikael N; Mirza NM; Zaharian BI; Deulofeut H; Salazar M; Yunis EJ; Dubey DP
    Growth Dev Aging; 1994; 58(1):3-12. PubMed ID: 8077079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific T-lymphocyte cytotoxicity enhanced by low dose of C. parvum.
    Lau BH; Wang-Cheng RM; Tosk J
    J Leukoc Biol; 1987 May; 41(5):407-11. PubMed ID: 3494802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
    Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
    Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulation of NK and ADCC by Corynebacterium parvum in acute myeloid leukaemia patients.
    Hokland P; Ellegaard J
    Leuk Res; 1985; 9(1):175-84. PubMed ID: 3857405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulation by Corynebacterium parvum in normal humans.
    Hokland P; Ellegaard J; Heron I
    J Immunol; 1980 May; 124(5):2180-5. PubMed ID: 6154095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting stimulation of natural cytotoxicity to a rat lymphoma by Corynebacterium parvum.
    Flexman JP; Shellam GR
    Br J Cancer; 1980 Jul; 42(1):41-51. PubMed ID: 6968570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kupffer cell stimulation with Corynebacterium parvum reduces some cytochrome P450-dependent activities and diminishes acetaminophen and carbon tetrachloride-induced liver injury in the rat.
    Raiford DS; Thigpen MC
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):36-45. PubMed ID: 7974494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise training and mouse mammary tumour metastasis.
    Hoffman-Goetz L; May KM; Arumugam Y
    Anticancer Res; 1994; 14(6B):2627-31. PubMed ID: 7872692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
    Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
    J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
    Dussault I; Miller SC
    Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of Dimethoxane (CAS No. 828-00-2) (Commercial Grade) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Sep; 354():1-191. PubMed ID: 12704430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.